Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel defined programmed cell death related gene signature for predicting the prognosis of serous ovarian cancer

29 Apr 2024

Abstract excerpt

PURPOSE: This study aims to explore the contribution of differentially expressed programmed cell death genes (DEPCDGs) to the heterogeneity of serous ovarian cancer (SOC) through single-cell RNA sequencing (scRNA-seq) and assess their potential as predictors for clinical prognosis. METHODS: SOC scRNA-seq data were extracted from the Gene Expression Omnibus database, and the principal component analysis was used...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Single-cell and spatial transcriptomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38685095
DOI: 10.1186/s13048-024-01419-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel defined programmed cell death related gene signature for predicting the prognosis of serous ovarian cancerPMID 38685095Read ↗

Multi‑omics identification of a novel signature for serous ovarian carcinoma in the context of 3P medicine and based on twelve programmed cell death patterns: a multi-cohort machine learning studySemantic proximity Read ↗

Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancerSemantic proximity Read ↗

A Nine-Immune-Related Gene Prognostic Signature for Predicting Outcomes in High-Grade Serous Ovarian CancerSemantic proximity Read ↗

Development of a necroptosis-related gene signature and the immune landscape in ovarian cancerSemantic proximity Read ↗

Characterizing tumor biology and immune microenvironment in high-grade serous ovarian cancer via single-cell RNA sequencing: insights for targeted and personalized immunotherapy strategiesSemantic proximity Read ↗

Subtype-specific analysis of gene co-expression networks and immune cell profiling reveals high grade serous ovarian cancer subtype linkage to variable immune microenvironmentSemantic proximity Read ↗

Disulfidptosis-related prognostic model based on multiomics and the significance of IL1B in ovarian cancerSemantic proximity Read ↗

Immune cell landscapes are associated with high-grade serous ovarian cancer survivalSemantic proximity Read ↗

Ovarian cancer‐specific dysregulated genes with prognostic significance: scRNA‐Seq with bulk RNA‐Seq data and experimental validationSemantic proximity Read ↗

Genomic, Immunological, and Clinical Characterization of Pyroptosis in Ovarian CancerSemantic proximity Read ↗

Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy.Semantic proximity Read ↗

Identification of parthanatos-related molecular subtypes and development of prognostic risk models in ovarian cancer based on multi-omics analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.